UR.EXO | UR.mscS RAIOME contact fertility cosmetic testing surgical cellular about

Legal & Regulatory Notice

RAIOA (Reverse Aging Institute of America) is committed to transparency, compliance, and patient safety. The information provided on this website is for educational purposes only and should not be interpreted as medical advice or a substitute for professional consultation with a qualified healthcare provider.

Regulatory Status of Stem Cell & Exosome Therapies

  • At this time, no stem cell or exosome products are approved by the U.S. Food and Drug Administration (FDA) for the prevention, treatment or cure of any disease or medical condition.

  • Research into the potential applications of mesenchymal stem cells (MSCs), exosomes, and placental tissues is ongoing. While early findings are promising, many applications remain experimental.

  • Availability of procedures and therapies varies significantly by jurisdiction and may be subject to specific local or national regulations.

Access & Availability

RAIOA works with patients and their medical providers to explore options in regions where therapies may be:

  • Legally permitted under local regulations.

  • Delivered in compliance with established safety standards.

  • Ethically administered under the supervision of qualified practitioners.

Patients interested in regenerative procedures are encouraged to discuss risks, benefits, and regulatory considerations with their healthcare team.

No Guarantee of Outcomes

  • RAIOA does not guarantee specific medical outcomes or results.

  • The decision to pursue any treatment should be based on an individualized consultation with a licensed physician.

  • Patients must be aware that regenerative therapies are not considered standard of care and may not be covered by insurance.

Informed Consent

Any participation in regenerative procedures requires informed consent. This means patients will be fully educated about the experimental nature of treatments, potential benefits, limitations, and risks before proceeding.

Contact

If you have questions regarding availability, regulatory compliance, or patient pathways, please contact RAIOA directly.